Personal mental health histories lead to investments in psychedelics research

Two North American entrepreneurs have put millions of dollars into exploring the treatment efficacy of psychedelics, based on personal experience of using them to help deal with their own mental health issues.

Toronto-based charity the Nikean Foundation has made a CAD $5m donation to research into the use of psychedelics at the Toronto University Health Network (UHN), while Journey Clinical of New York has raised USD $3m for research into psychedelic-assisted psychotherapy.


Restricted content. Do you want to read more?